When BCBS covers Zepbound, typical PA requirements include: BMI 30 or 27 with a comorbidity (hypertension, type 2 diabetes, high cholesterol, or OSA), 6 months of documented lifestyle modification (diet and exercise program), and sometimes step therapy requiring trial of other weight loss medications first
Individuals who are pregnant or breastfeeding, those with certain medical conditions such as severe liver or kidney disease, or those with an active infection or skin condition in the treatment area should avoid fat-dissolving injections
While emerging data hint that GLP-1 therapies may offer added benefits, the evidence remains preliminary, and careful interpretation is essential
It does so by eliminating harmful substances like heavy metals and environmental toxins
1 Exendin-4 treatment restores AD-induced reductions of GLUT3 and PGC-1 expressions in neurons
Its strengths lie precisely where sermorelin falls short